Strain-dependent induction of allergic rhinitis without adjuvant in mice

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 6, 1999, Pages 593-601

  Harn Jr , D A ^a   Abe, M ^a   Wang, M M ^a   Satoskar, A R ^a   Nishizaki, K ^b   Masuda, Y ^b   Yoshino, T ^b   Okano, Mitsuhiro ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Adjuvant; Allergic rhinitis; Cytokine; Eosinophilia; IgE; Intranasal sensitization; Mouse; Strain

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 5;

ALLERGIC RHINITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; FEMALE; GENE CONTROL; IMMUNOGLOBULIN PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SENSITIZATION;

ANIMALS; DISEASE MODELS, ANIMAL; EGG PROTEINS; EOSINOPHILIA; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-5; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; RHINITIS, ALLERGIC, PERENNIAL; SCHISTOSOMA MANSONI; SPECIES SPECIFICITY;

EID: 0033004598     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00063.x     Document Type: Article

References (53)

1. 1. Okada M, Shida T. Clinical aspects of Japanese cedar pollinosis. Allergol Int 1998;47:1-8.
2. 2. Murray AB, Anderson DO. The epidemiologic relationship of clinical nasal allergy to cosinophilia and to goblet cells in the nasal smear. J Allergy 1969;43:1-8.
3. 3. Okano M, Nishizaki K, Nakada M, et al. Prevalence and prediction of allergic rhinitis using questionnaire and nasal smear examination in schoolchildren. Acta Otolaryngol (Stockh) 1999 (in press).
4. 4. Sibbald B, Rink E. Labeling of rhinitis and hay fever by doctors. Thorax 1991;46:378-381.
5. 5. Richards S, Thornhill D, Roberts H, Harries U. How many people think they have hay fever, and what they do about it. Br J Gen Pract 1992;42:284-286.
6. 6. Collee JM, ten Kate LP, de Vries HG, et al. Allele sharing on chromosome 11q13 in sibs with asthma and atopy. Lancet 1993;342:936.
7. 7. Enander B, Ahlstedt S. Regional and systemic immune responses to trinitrophenyl derivatives after intranasal and subcutaneous sensitization of mice. J Allergy Clin Immunol 1985;75:37-43.
8. 8. Ahlstedt S, Björkstén B. Specific antibody responses in rats and mice after daily immunization without adjuvant. Int Arch Allergy Appl Immunol 1983;71:293-299.
9. 9. Tamura S, Shoji Y, Hasiguchi K, Aizawa C, Kurata T. Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin. Vaccine 1994;12:1238-1240.
10. 10. Ahlstedt S, Björkstén B, Nygren H, Smedegard G. Induction of humoral immunity and pulmonary mast cells in mice and rats after immunization with aerosolized antigen. Immunology 1983;48;247-254.
11. 11. McCaskill AC, Hosking CS, Hill DJ. IgE and haemagglutinating antibody production in mice following intranasal immunization with ryegrass pollen. Int Arch Allergy Appl Immunol 1982;67:191-193.
12. 12. Takafuji S, Suzuki S, Koizumi K, et al. Diesel-exhaust particles inoculated by the intranasal route have an adjuvant activity for IgE production in mice. J Allergy Clin Immunol 1987;79:639-645.
13. 13. Renz H, Smith HR, Henson JE, Ray BS, Irvin CG, Gelfand EW. Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. J Allergy Clin Immunol 1992;89:1127-1138.
14. 14. Holt PG, Batty JE, Turner KJ. Inhibition of specific IgE responses in mice by pre-exposure to inhaled antigen. Immunology 1981;42:409-417.
15. 15. Maejima K, Tamura K, Taniguchi Y, Nagase S, Tanaka H. Comparison of the effects of various fine particles on IgE antibody production in mice inhaling Japanese cedar pollen. J Toxicol Environ Health 1997;52:231-248.
16. 16. Bomford R. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect of the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin. Clin Exp Immunol 1980;39:426-434.
17. 17. Tomilson LA, Christie JF, Fraser DM, McLaughlin D, McIntosh AE, Kennedy MW. MHC restriction of the antibody repertoire to secretory antigens, and major allergen, of the nematode parasite Ascaris. J Immunol 1989;143:2349-2356.
18. 18. Valensi JPM, Carlson JR, van Nest GA. Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants. J Immunol 1994;153:4029-4039.
19. 19. Mountford AP, Anderson S, Wilson RA. Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant. J Immunol 1996;156:4739-4745.
20. 20. Karagouni EE, Hadjipetrou-Kourounakis L. Regulation of isotype immunoglobulin production by adjuvant in vitro. Scand J Immunol 1990;32:745-754.
21. 21. Victorias P, Yiangou M, Avramisis N, Hadipetrou L. Regulation of cytokine gene expression by adjuvants in vivo. Clin Exp Immunol 1997;109:569-578.
22. 22. Diaz-Sanchez D, Tsien A, Fleming J, Saxon A. Combined diesel exhaust particle and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern. J Immunol 1997;158:2406-2413.
23. 23. Grzych JM, Pearce E, Cheever A, et al. Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J Immunol 1991;146:1322-1327.
24. 24. Smithers SR, Doenhoff MJ. Schistosomiasis. In: Cohen S, Warren KS, editors. Immunology of parasitic diseases. Oxford: Blackwell Scientific, 1982:527-607.
25. 25. Lukacs NW, Strieter RM, Warmington K, Lincoln P, Chensue SW, Kunkel SL. Differential recruitment of leukocyte population and alteration of airway hyperreactivity by C·C family chemokines in allergic airway inflammation. J Immunol 1997;158:4389-4404.
26. 26. Asanuma H, Inaba Y, Aizawa C, Kurata T, Tamura S. Characterization of mouse nasal lymphocytes isolated by enzymatic extraction with collagenase. J Immunol Methods 1995;187:41-51.
27. 27. Robinson MK, Babcock LS, Horn PA, Kawabata TT. Specific antibody responses to subtilisin Carlsberg (alcalase) in mice: development of an intranasal exposure model. Fundam Appl Toxicol 1996;34:15-24.
28. 2 of honeybee venom. Immunologist 1986;23:417-420.
29. 29. Kawabata TT, Babcock LS, Horn PA. Specific IgE and IgG1 responses to subtilisin Carlsberg (alcalase) in mice: development of an intratracheal exposure model. Fundam Appl Toxicol 1996;29:238-243.
30. 30. Fanning MM, Peters PA, Davis RS, Kazura JW, Mahmoud AAF. Immunopathology of murine infection with Schistosoma mansoni: relationship of genetic background to hepatosplenic disease and modulation. J Infect Dis 1981;144:148-153.
31. 31. Hernandez NJ, Trzyna WC, Cordingley JS, Brodeur PH, Stadecker MJ. Differential antigen recognition by T cell populations from strains of mice developing polar forms of granulomatous inflammation in response to eggs of Schistosoma mansoni. Eur J Immunol 1997;27:666-670.
32. 32. Velupillai P, Secor WE, Horauf AM, Ham DA. B-1 cell (CD5+B220+) outgrowth in murine schistosomiasis is genetically restricted and is largely due to activation by polylactosamine sugars. J Immunol 1997;158:338-344.
33. 33. Amiri P, Haak-Frendscho M, Robbins K, McKerrow JH, Stewart T, Jardieu P. Anti-immunoglobulin E treatment decreases worm burden and egg production in Schistosoma mansoni-infected normal and interferon-γ knockout mice. J Exp Med 1996;180:43-51.
34. 34. Renauld-Mongenie G, Mielcarek N, Cornette J, et al. Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recumbinant Bordetella pertussis. Proc Natl Acad Sci U S A 1996;93:7944-7949.
35. 35. Xiao Y, Kurono Y, Ichiyama I, Mogi G. Induction of antigen-specific antibody-secreting cells in the nasal mucosa by intranasal immunization in BALB/c mice. Acta Otolaryngol (Stockh) 1998;118:124-130.
36. 36. Uchida T, Horino A, Naito S, Mizuguchi J. IgE-specific unresponsiveness in mice induced by ovalbumin coupled with murine red blood cells. Int Arch Allergy Immunol 1994;104:405-408.
37. 37. Usui M, Matsuhashi T. IgE-selective and antigen-specific unresponsiveness in mice. I. Induction of the unresponsiveness by administration of ovalbumin-pullulan conjugate. J Immunol 1979;122:1266-1272.
38. 38. Taniguchi Y, Ikegami H, Usui M, et al. Biological and immunological properties of Sugi basic protein-pullulan conjugate. I. Suppressive effect on IgE antibody production and on IgE-mediated reactions. Int Arch Allergy Appl Immunol 1989;89:136-142.
39. 39. Cheng KC, Lee KM, Krug MS, et al. House dust mite-induced sensitivity in mice. J Allergy Clin Immunol 1998;101:51-59.
40. 40. Ko AI, Drager UC, Harn DA. A Schistosoma mansoni epitope recognized by a protective monoclonal antibody is identical to the stage-specific embryonic antigen 1. Proc Natl Acad Sci U S A 1990;87:4159-4163.
41. 41. Velupillai P, Harn DA. Oligosaccharide-specific induction of interleukin 10 production by B220+ cells from schistosome-infected mice: a mechanism for regulation of CD4+ T-cell subsets. Proc Natl Acad Sci U S A 1994;91:18-22.
42. 42. Palanivel V, Posey C, Horauf AM, Solbach W, Piessens WF, Harn DA. B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases. Exp Parasitol 1996;84:168-177.
43. 43. Tian J, Atkinson MA, Clare-Salzler M, et al. Nasal administration of glutamine decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 1996;183:1561-1567.
44. 44. Nelson DJ, McMenamin C, McWilliam AS, Brenan M, Holt PG. Development of the airway intraepithelial dendritic cell network in the rat from class II major histocompatibility (Ia)-negative precursors: differential regulation of Ia expression at different levels of the respiratory tract. J Exp Med 1994;179:203-212.
45. 45. Hirabayashi Y, Kurata H, Funato H, et al. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parental vaccination. Vaccine 1990;8:243-248.
46. 46. Corrigan CJ, Kay AB. T cells and cosinophils in the pathogenesis of asthma. Immunol Today 1992;13:501-507.
47. 47. Nishioka K, Saito C, Nagano T, Okano M, Masuda Y, Kuriyama T. Eosinophil cationic protein in the nasal secretions of patients with mite allergic rhinitis. Laryngoscope 1993;103:189-192.
48. 48. Lukacs NW, Strieter RM, Shaklee CL, Chensue SW, Kunkel SL. Macrophage inflammatory protein-1a influences cosinophil recruitment in antigen-specific airway inflammation. Eur J Immunol 1995;25:245-251.
49. 49. Yamaguchi Y, Suda T, Suda J, et al. Purified interleukin 5 (IL-5) supports the terminal differentiation and proliferation of murine cosinophilic precursors. J Exp Med 1988;167:43-56.
50. 50. Coffman RL, Seymour BW, Hudak S, Jackson J, Rennick D. Antibody to interleukin-5 inhibits helminth-induced cosinophilia in mice. Science 1989;245:308-310.
51. 51. Durham SR, Ying S, Varney VA, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue cosinophilia. J Immunol 1992;148:2390-2394.
52. 52. Mauser PJ, Pitman A, Witt A, et al. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis 1993;148:1623-1627.
53. 53. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes cosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996;183:195-201.